Interleukin Inhibitors in Brief

Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.

Related Videos
Natalie McCormick, PhD | Credit: American College of Rheumatology
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Related Content

APPLE Study Analysis Provides New Insight into Heterogeneity in Pediatric Systemic Lupus Erythematosus

June 2nd 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

June 1st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid Arthritis

May 31st 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

May 31st 2023

APPLE Study Analysis Provides New Insight into Heterogeneity in Pediatric Systemic Lupus Erythematosus

June 2nd 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

June 1st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid Arthritis

May 31st 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

May 31st 2023

APPLE Study Analysis Provides New Insight into Heterogeneity in Pediatric Systemic Lupus Erythematosus

June 2nd 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout Patients

June 1st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid Arthritis

May 31st 2023

Report: For US Patients, Gout Burden Greatest Among Asian Americans

May 31st 2023
© 2023 MJH Life Sciences

All rights reserved.